mRNA Patent Litigation: The ‘Sport of Kings’
SpicyIP
SEPTEMBER 5, 2022
This David v. Due to its focus on mRNA technology and research in this field, once the genomic sequence for SAR-CoV-2 was published, Moderna was able to produce its vaccine at a lightning-fast pace. As claimed, fair compensation will allow it to invest in its leading mRNA platform.
Let's personalize your content